TruDiagnostic offers a test called TruAge, which looks at over 900,000 methylation markers. TruAge measures Biological Age in addition to a full suite of aging-related metrics. This includes telomere length measurements, intrinsic and extrinsic age calculations, immune cell subset deconvolution, epigenetic age, and the current rate of aging.
Information from these diagnostic test reports can potentially facilitate preventive health care and management for some age-related illnesses such as cancer, Parkinson’s, and Alzheimer’s.
TruDiagnostic is based in Lexington, Kentucky, established in 2020 with a visionary approach to healthcare. Specializing in epigenetic testing, TruDiagnostic aims to transform the Health and Aging industry by enabling deeper insights into the biological mechanisms that govern aging and related diseases.
TruDiagnostic operates with a mission t”o help people understand, access, and benefit from their epigenome. We also research & develop epigenetic analysis methods in the effort to create new methylation-based medical diagnostic tools.”
Their efforts are concentrated on ongoing research and development of new diagnostic tools which are critical for the early detection and management of diseases. By focusing on the epigenome, TruDiagnostic aims to revolutionize not only how to understand aging but also how to reverse or mitigate its effects.
At the heart of TruDiagnostic's offerings is the TruAge test, a comprehensive diagnostic tool that examines over 900,000 methylation markers to assess biological age and various aging-related metrics.
TruAge goes beyond simple age measurement to provide a detailed analysis including telomere length, intrinsic and extrinsic age calculations, immune cell subset deconvolution, epigenetic age, and the current rate of aging.
TruDiagnostic stands out in the field of epigenetic testing for its stringent adherence to high testing standards, ensuring the accuracy and reliability of every diagnostic report. The company's commitment to excellence is reflected in their rigorous protocols and the advanced technologies they employ.
TruDiagnostic is CLIA-Certified and CAP-Accredited.
The TruAge Complete Collection is one of the most comprehensive offerings from TruDiagnostic, utilizing a blood spot sample to provide a suite of epigenetic aging reports and algorithms.
This test includes the Dunedin PACE, a novel aging algorithm that is the only one of its kind publicly available. Unlike traditional models, Dunedin PACE is trained on phenotypes and health variables rather than chronological age, making it a more accurate predictor of biological aging.
The collection has recently been expanded to include OMICm Age, developed in partnership with Harvard University. OMICm Age is hailed as the most advanced and predictive aging algorithm created to date, offering novel insights into the reasons behind accelerated biological aging in individuals.
Additionally, the collection assesses other age-related factors like blood sugar, inflammation, and fitness age, enabling personalized interventions to mitigate age-related health risks effectively.
Building on the foundational elements of the Complete Collection, the TruAge PACE test focuses specifically on the biological pace of aging. Utilizing a blood spot sample, this test evaluates short-term changes in methylation patterns that have long-term impacts on health.
It incorporates the Dunedin PACE algorithm, providing a focused assessment of how a person's biological age is progressing in relation to their chronological age.
This test is particularly valuable for individuals interested in understanding and potentially mitigating the effects of accelerated aging.
The PgX Test from TruDiagnostic represents a significant advancement in the field of pharmacogenomics. Conducted with a simple swab sample, this test analyzes a patient's genetic makeup to identify variations that may affect drug metabolism.
Understanding these genetic variations can greatly influence how medications are prescribed, allowing for more personalized treatment plans that optimize drug efficacy and minimize adverse effects.
This test is essential for anyone on long-term medication or those experiencing issues with standard drug dosages.
TruDiagnostic offers a test called TruAge which looks at over 900,000 methylation markers. TruAge measures Biological Age in addition to a full suite of aging related metrics. This includes telomere length measurements, intrinsic and extrinsic age calculations, immune cell subset deconvolution, current pace of aging, and more.
.jpg)
